Track record · closed signal

Ecovyst Inc. (ECVT) — closed signal from May 8, 2026

Partial Published before the outcome was known, scored automatically when the window closed on August 6, 2026 — -21.1% at the close.

Predicted vs. what happened

ECVT price · publication thesis → realized outcomesplit-adjusted

$13.40 – $14.10Entry zone — fair-value band

$13.94Published — price the day we called it

$15.47Target — the price the thesis aimed for

$15.09Peak — highest point inside the window, not a realized return

$11.00Window close — end-of-window price, context only

What happened

Partial

Reached 75% of the predicted growth at its peak, without hitting the target.

At window close

-21.1%

realized, from the publication price to the last close inside the window

Peak gain

+8.3%

peak, from the publication price — not a realized return

S&P 500, same window

+4.5%

SPY over the identical days, dividend-adjusted

Window close

$11.00

last close inside the window, ended August 6, 2026

Peak price

$15.09

peak on May 14, 2026 — not a realized return

Days to target

—

The thesis — published May 8, 2026

Predicted growth

+11%

over the measurement window

Target price

$15.47

the price the thesis aimed for

Entry zone

$13.40 – $14.10

the fair-value band we waited for

Price at publication

$13.94

published May 8, 2026

Confidence

73%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

Recent company updates show much higher adjusted profits, a clearer short-term operating plan and an acquisition that could widen its specialty-chemicals work. Strong balance-sheet cash makes executing those plans more realistic. However, official accounting profits are weak and trading volume is light, so the rebound looks selective and needs proof that margins hold up.

Primary drivers

Adjusted profits rose sharply, signaling improving earnings quality
Clearer short-term operating outlook increases predictability
Acquisition could expand specialty-chemicals products and markets
Strong balance sheet gives flexibility to fund plans and absorb shocks

How it played out

ECVT: early rise fell short of the target

Lyra published ECVT at $13.94, expecting 11% growth over the short-term window. The thesis pointed to sharply higher adjusted profits, a clearer operating outlook, an acquisition that could expand its specialty-chemicals business, and balance-sheet cash that could support execution. It also noted weak official profits and light trading volume.

ECVT rose to a $15.09 peak on May 14, an 8.3% gain from publication. The price stayed below the $15.47 target, so the expected 11% gain was never reached. By August 6, it had fallen to $11. The thesis partially played out early, but it missed its stated target and did not hold the rebound.

What happened during the window

On June 30, Ecovyst completed its acquisition of the Calabrian sulfur dioxide and related derivatives business. On August 5, the company reported second-quarter sales up 42% and adjusted EBITDA up 27%, and raised its 2026 outlook.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All ECVT signals